Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
5439 studies found for:    lymphoma
Show Display Options
Rank Status Study
1 Completed Observational Study in Participants With Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM) and Non-Hodgkin's Lymphoma (NHL) in Latin America
Conditions: Multiple Myeloma;   Leukemia;   Lymphoid;   Lymphoma;   Non-Hodgkin
Interventions: Other: Chronic Lymphocytic Leukemia (CLL);   Other: Multiple Myeloma (MM);   Other: Non-Hodgkin's lymphoma (NHL)
2 Active, not recruiting
Has Results
Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)
Condition: Diffuse Large B-cell Lymphoma
Interventions: Drug: Lenalidomide;   Drug: Gemcitabine;   Drug: Oxaliplatin;   Drug: Rituximab;   Drug: Etoposide
3 Completed Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma
Condition: Lymphoma
Interventions: Biological: rituximab;   Drug: bortezomib;   Drug: carboplatin;   Drug: dexamethasone;   Drug: etoposide;   Drug: ifosfamide;   Genetic: polymerase chain reaction;   Genetic: western blotting
4 Recruiting Immunotherapy for Asymptomatic Phase Lymphoplasmacytic Lymphoma
Conditions: Lymphoma;   Lymphoplasmacytic Lymphoma;   Waldenström Macroglobulinemia
Intervention: Biological: DNA Vaccine
5 Active, not recruiting Combined Rituximab and Lenalidomide Treatment for Untreated Patients With Follicular Lymphoma
Condition: Follicular Lymphoma
Interventions: Drug: Rituximab;   Drug: Lenalidomide;   Drug: Rituximab-CHOP;   Drug: Rituximab-CVP;   Drug: Rituximab-Bendamustine
6 Recruiting Molecular and Whole-body MR Imaging in Lymphomas
Conditions: Lymphoma;   Hodgkin Disease;   Lymphoma, Non-Hodgkin
Intervention: Other: 68Ga-DOTANOC PET/CT; Diffusion weighted MRI
7 Active, not recruiting Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas
Conditions: Follicular Lymphoma;   Marginal Zone B-Cell Lymphoma;   MALT Lymphoma;   Lymphoma of Mucosa-Associated Lymphoid Tissue;   Lymphoma, Small Lymphocytic;   Waldenstrom Macroglobulinemia;   Mantle-Cell Lymphoma
Interventions: Drug: lenalidomide-low dose dexamethasone plus rituximab;   Drug: Lenalidomide + Rituximab
8 Completed An Observational Study of Lymphoma in Patients With Rheumatoid Arthritis or Crohn's Disease.
Condition: Lymphoma
Intervention: Other: No intervention
9 Withdrawn Combined CT Colonography and PET Imaging in Mantle Cell Lymphoma
Conditions: Mantle Cell Lymphoma;   Lymphoma
Intervention: Procedure: PET/CT Scanning
10 Completed
Has Results
Imexon for Relapsed Follicular and Aggressive Lymphomas
Conditions: Follicular Lymphoma;   Small Lymphocytic Lymphoma;   Marginal Zone Lymphoma;   Lymphoplasmacytic Lymphoma;   Diffuse Large B Cell Lymphoma;   Mantle Cell Lymphoma;   Burkitt's Lymphoma
Intervention: Drug: Imexon
11 Completed Study of Blood and Tissue Samples From Patients With Aggressive Non-Hodgkin B-Cell Lymphoma or Hodgkin Lymphoma
Conditions: Lymphoma;   Nonneoplastic Condition
Interventions: Genetic: polymerase chain reaction;   Other: laboratory biomarker analysis
12 Recruiting Clinical Cohort of Lymphoma Patients in Malawi
Conditions: Lymphoma;   Hematologic Malignancies
Intervention:
13 Completed
Has Results
UCN-01 (7-Hydroxystaurosporine) to Treat Relapsed T-Cell Lymphomas
Conditions: Lymphoma, Large-Cell, Ki-1;   Lymphoma, T-Cell
Intervention: Drug: UCN-01 (7-hydroxystaurosporine)
14 Completed Biaxin Based Antibiotic Therapy in Previously Untreated, Advanced Stage Indolent Lymphoma
Condition: Lymphoma
Interventions: Drug: BIAXIN (CLARITHROMYCIN);   Drug: Biaxin (clarithromycin)
15 Recruiting Observational Controlled Clinical Trials, on Adult Patients With T-lymphoblastic Lymphoma Treated With Intensive Chemo/Radiotherapy or Intensive Chemotherapy Followed by Transplant. Evaluation of Clinical, Anatomy -Pathological Parameters
Condition: Lymphoblastic Lymphoma
Intervention: Other: Latest generation chemotherapies for T-LBL + transplant
16 Completed Study of Canfosfamide in Refractory or Relapsed Mantle Cell, Diffuse Large B Cell Lymphoma and Multiple Myeloma
Conditions: Mantle Cell Lymphoma;   B Cell Lymphoma;   Multiple Myeloma
Intervention: Drug: Canfosfamide HCl for injection
17 Completed
Has Results
Study of SyB L-0501 in Combination With Rituximab to Treat Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Conditions: Non-Hodgkin's Lymphoma;   Lymphoma, Large Cell;   Diffuse, Mantle Cell Lymphoma, Lymphoma;   Follicular Lymphoma;   Large B-Cell, Diffuse
Interventions: Drug: SyB L-0501;   Drug: Rituximab
18 Recruiting Brazilian Network for Lymphoma Registry
Condition: Lymphoma
Intervention: Other: Observational, non-intervention
19 Completed Phase 1b Lymphoma Study of AMG 655 in Combination With Bortezomib or Vorinostat
Conditions: Hodgkin's Lymphoma;   Low Grade Lymphoma;   Lymphoma;   Mantle Cell Lymphoma;   Non-Hodgkin's Lymphoma;   Diffuse Large Cell Lymphoma
Interventions: Drug: AMG 655;   Other: Vorinostat;   Other: Bortezomib
20 Active, not recruiting Vaccination for the Treatment of Previously Untreated or Relapsed Follicular Lymphoma
Condition: Follicular Lymphoma
Intervention: Biological: Lethally Irradiated Lymphoma cells with GM-CSF K562 Cells

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years